TITLE

Simple test screens genetics disease

AUTHOR(S)
Anderson, Ian
PUB. DATE
October 1991
SOURCE
New Scientist;10/26/91, Vol. 132 Issue 1792, p25
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Describes the QUT process, a test that could speed up the mass screening of large numbers of people on genetic diseases such as cystic fibrosis and sickle cell anemia. Identification of carriers of genetic diseases; Capability of the process to identify several variants of hemophilia and other blood diseases; Use of a DNA primer to simplify and speed up the process.
ACCESSION #
10556413

 

Related Articles

  • ESTADO ACTUAL DE LA PESQUISA NEUROMETABOLICA NEONATAL. Alfonso, Israel; Charria, Gustavo; Papazian, Oscar // Medicina (Buenos Aires);2009, Vol. 69 Issue 1, p36 

    The purpose of neurometabolic screening is the earliest possible detection of treatable disorders. The disorders currently offered to general population screening are phenylketonuria, congenital hypothyroidism, galactosemia, congenital adrenal hyperplasia, cystic fibrosis, biotinidase...

  • Let's play our part in the screening programme. Clift-Matthews, Victoria // British Journal of Midwifery;Dec2006, Vol. 14 Issue 12, p692 

    The article discusses the author's perspectives on newborn medical screening program in Great Britain. The author inferred that all parents in the country are now being offered with newborn screening for phenylketonuria and congenital hypothyroidism. She believed that the national program for...

  • Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges. Parker, Hilda; Qureshi, Nadeem; Ulph, Fiona; Kai, Joe // BMC Health Services Research;2007, Vol. 7, p203 

    Background: Universal newborn screening for early detection of children affected by sickle cell disorders and cystic fibrosis is currently being implemented across England. Parents of infants identified as carriers of these disorders must also be informed of their baby's result. However there is...

  • Old meets new: identifying founder mutations in genetic disease. Evans, Jane A. // CMAJ: Canadian Medical Association Journal;2/3/2015, Vol. 187 Issue 2, p93 

    The author reflects on her concerns on the potential of modern methods for gene identification to improve outcomes for patients, their families, and communities. Topics include autosomal recessive disorders common in Inuit populations, the possibility of introduction of alleles from other groups...

  • Newborn screening for cystic fibrosis. David, T. J. // Journal of the Royal Society of Medicine;May2004, Vol. 97 Issue 5, p209 

    The article comments on the national screening program for cystic fibrosis among children in England, and discusses the problems involve in the program implementation. The author points out that the screening program was more political than scientific, with continual arguments on its possible...

  • Newborn Screening Strides. Lee, Katherine // Working Mother;Nov2007, Vol. 30 Issue 8, p98 

    The article presents the findings of the study which reveals that 88% of newborns receive screening for serious diseases which are recommended by the American College of Medical Genetics (ACMG) in the U.S. However, March of Dimes (MOD) president Jennifer Howse asserts that doctors give more...

  • Should States Retain Newborn Blood Samples? Jacobson, Robert // U.S. News Digital Weekly;4/18/2014, Vol. 6 Issue 16, p15 

    The article focuses on the issue on whether the newborn blood samples must be retained by states. It says that the preservation of the newborn screening blood spots are recommended by many medical experts for the assurance of the proper diagnosis of disorders, like sickle cell anemia, cystic...

  • Cystic fibrosis newborn screening enables diagnosis of elder siblings of recalled infants – additional benefit. Sands, Dorota; Zybert, Katarzyna; Nowakowska, Anna // Folia Histochemica et Cytobiologica;2010, Vol. 48 Issue 1, p163 

    The different clinical manifestations of cystic fibrosis, with variable intensity and timing, often delay the diagnosis of this genetic autosomal recessive disorder. Many countries have introduced newborn screening for cystic fibrosis to facilitate diagnosis prior to the development of the...

  • Front Porch.  // Southern Jewish Life;Nov2012, Vol. 22 Issue 11, p5 

    The article offers information on a community-wide screening for genetic diseases to be held at the Levite Jewish Community Center in Birmingham, Alabama on January 13, 2013 of interest to Jews with central and Eastern European descent. It mentions the possibility of carrying a preventable...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics